Sigma Healthcare (ASX: SIG) delivers strong double‑digit growth and disciplined integration, positioning the merged Chemist Warehouse group for sustained expansion across domestic and international markets
.webp&w=828&q=75)
HUB24 Limited (ASX: HUB) delivers record inflows, expanding margins, and disciplined execution, reinforcing its leadership in wealth‑tech platforms and positioning for sustained shareholder value through scalable growth
.webp&w=828&q=75)
Kingsgate delivered stronger FY26 production with higher gold and silver output, but KCN now tests key chart support. Investors watch the A$4.05–A$4.15 zone, Chatree performance, and future growth from Nueva Esperanza
We believe Collins Foods (ASX: CKF) is entering a multi-year earnings recovery cycle anchored by margin repair in Australia, operational rejuvenation in Europe, clear line-of-sight to double-digit EBITDA growth, and an improving balance sheet that gives management options rather than constraints. The HY26 results demonstrate that CKF is moving decisively out of the inflation shock period that suppressed margins and elevated operating costs between 2022–2024. With commodity and utilities inflation easing, labour efficiencies improving, and price/mix still resilient, we see structural tailwinds forming beneath the company’s operating base.
We view Telstra as a highly resilient, structurally advantaged cash-generating business within the Australian equity market, offering strong earnings quality and downside protection despite limited headline growth. Its focus on network leadership, disciplined capital management and monetisation of digital and infrastructure assets supports stable free cash flow and reliable capital returns, particularly in a softer macro environment. We believe the market continues to undervalue Telstra’s leverage to long-term data demand, the durability of its mobile economics, and the embedded optionality in InfraCo and enterprise digital services.
Transurban is a high-quality global infrastructure franchise with long-duration, inflation-protected cash flows, strong pricing power and irreplaceable assets. The market remains overly focused on macro headwinds, overlooking the durability of its concessions, recovering mobility and improving cash-flow conversion. As operational risk declines and cost pressures fade, Transurban is well positioned to deliver asymmetric upside through FY26–FY28 via compounding distributions and operating leverage.
...
